FDA’s Jennifer Dickey Provides a Regulatory Review of Clinical Sequencing Assays

At the 2014 Next Generation Dx Summit, U.S. FDA’s Office of In Vitro Diagnostics’ Dr. Jennifer Dickey provided a regulatory update on clinical sequencing assays. Learn more about the event at http://www.nextgenerationdx.com